CMFRI, Library (2022) CMFRI develops a seaweed-based natural treatment for fatty liver disease News Track dated 27th September 2022. News Track.
|
Text
News Track_27-09-2022.pdf Download (101kB) | Preview |
Official URL: https://english.newstracklive.com/news/cmfri-devel...
Related URLs:
Abstract
To treat non-alcoholic fatty liver disease, the Central Marine Fisheries Research Institute (CMFRI) in this city has developed a nutraceutical product using specific seaweeds (NAFLD). The product, known as CadalminTM LivCure extract, is a special combination of 100 percent natural bioactive compounds derived from seaweeds using environmentally friendly green technology to enhance liver function.
Item Type: | Article |
---|---|
Subjects: | Algae > Seaweed CMFRI News Clippings |
Divisions: | Library and Documentation Centre |
Depositing User: | Mr. Augustine Sipson N A |
Date Deposited: | 14 Oct 2022 09:22 |
Last Modified: | 14 Oct 2022 09:22 |
URI: | http://eprints.cmfri.org.in/id/eprint/16335 |
Actions (login required)
View Item |